Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflammation.

× No keyword cloud information.

13 in total

1. Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1.

Authors: Chan Gyu Lee; Young Woo Kim; Eun Hyun Kim; Zhipeng Meng; Wendong Huang; Se Jin Hwang; Sang Geon Kim
Journal: Gastroenterology Date: 2012-01-18 Impact factor: 22.682

Review 2. Pharmacological agents for NASH.

Authors: Vlad Ratziu
Journal: Nat Rev Gastroenterol Hepatol Date: 2013-10-15 Impact factor: 46.802

Review 3. The role of inflammation in cholestasis: clinical and basic aspects.

Authors: Astrid Kosters; Saul J Karpen
Journal: Semin Liver Dis Date: 2010-04-26 Impact factor: 6.115

Review 4. Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.

Authors: M Arrese; S J Karpen
Journal: Clin Pharmacol Ther Date: 2010-03-03 Impact factor: 6.875

Review 5. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.

Authors: Claudia D Fuchs; Michael Trauner
Journal: Nat Rev Gastroenterol Hepatol Date: 2022-02-14 Impact factor: 73.082

Review 6. Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?

Authors: Swetha Rudraiah; Xi Zhang; Li Wang
Journal: Annu Rev Pharmacol Toxicol Date: 2016 Impact factor: 13.820

Review 7. Nonalcoholic fatty liver disease: new treatments.

Authors: Timothy Hardy; Quentin M Anstee; Christopher P Day
Journal: Curr Opin Gastroenterol Date: 2015-05 Impact factor: 3.287

Review 8. Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression.

Authors: Y Ilan
Journal: Aliment Pharmacol Ther Date: 2016-10-24 Impact factor: 8.171

Review 9. Recent advances in understanding and managing cholestasis.

Authors: Martin Wagner; Michael Trauner
Journal: F1000Res Date: 2016-04-19

10. FXR controls CHOP expression in steatohepatitis.

Authors: Claudia D Fuchs; Thierry Claudel; Hubert Scharnagl; Tatjana Stojakovic; Michael Trauner
Journal: FEBS Lett Date: 2017-10-11 Impact factor: 4.124